<DOC>
	<DOCNO>NCT00900328</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This laboratory study look tumor sample patient lung cancer .</brief_summary>
	<brief_title>Study Tumor Samples From Patients With Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine correlation c-Met expression , mutation amplification , stage overall survival patient adenocarcinoma ( AC ) lung . Secondary - To determine correlation epithelial mesenchymal transition ( EMT ) , EGFR mutation expression , Kras mutation , p53 mutation , c-CBL protein expression , mutation , loss heterozygosity ( LOH ) , DUB3 expression &amp; regulation , ALK translocation , respect survival . - To determine correlation circulate c-Met HGF AC evaluate prognostic implication circulate marker AC lung . - To determine ( available ) level circulate Met HGF serum surgery . OUTLINE : This multicenter study . Previously collect tissue sample patient enrol CALGB 140202 assess mutation analysis c-Met , EGFR , K-ras . DNA examine PCR , follow agarose gel electrophoresis ; gene amplification c-Met examine real time quantitative PCR ; met/HF protein serum examine ELISA ; c-Met , EGFR , p53 , c-CBL , DUB3 enzyme , ALK , epithelial mesenchymal transition examine IHC .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Registration Cancer Leukemia Group B ( CALGB ) 140202 Institutional Review Board ( IRB ) review approval institution laboratory work perform require Informed consent : CALGB require separate consent form sign study The subject population study protocol include patient select CALGB 140202 ; patient sign write informed consent document meeting federal , state , institutional guideline part entry trial All sample study obtain stored part CALGB 140202 ; material data obtain patient 's protocol record use obtain appropriate clinical information ; instance patient contact directly There physical , psychological , social , legal risk associate study ; invasive procedure recommend request All appropriate necessary procedure utilized maintain confidentiality ; patient sample submit analysis CALGB study number use identify specimen This study require direct patient contact specific risk benefit individual involve trial anticipate ; likely , however , information gain substantially help similar patient future</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage 0 non-small cell lung cancer</keyword>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>